Aurinia Suspends Voclosporin Development For Dry Eye, Staying Focused On Lupus
Biotech doesn’t shut the door on returning to ophthalmic formulation of the calcineurin inhibitor in dry eye but puts primary focus on oral voclosporin in lupus nephritis, with an FDA approval decision imminent.